MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

(2013) A. Ferrajoli et al.   BLOOD

MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia

(2012) M. Mraz et al.   BLOOD

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

(2012) Y. Zhang et al.   BLOOD

The B-cell receptor signaling pathway as a therapeutic target in CLL

(2012) J. A. Woyach et al.   BLOOD

miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes

(2012) Dan-Xia Zhu et al.   CARCINOGENESIS

The Role of B Cell Receptor Stimulation in CLL Pathogenesis

(2012) Laurens P. Kil et al.   CURRENT PHARMACEUTICAL DESIGN

SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155

(2012) Maria Grazia di Iasio et al.   INVESTIGATIONAL NEW DRUGS

Molecular pathogenesis of chronic lymphocytic leukemia

(2012) Gianluca Gaidano et al.   JOURNAL OF CLINICAL INVESTIGATION

Downregulation of Inflammatory MicroRNAs by Ig-like Transcript 3 Is Essential for the Differentiation of Human CD8+ T Suppressor Cells

(2012) C.-C. Chang et al.   JOURNAL OF IMMUNOLOGY

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155

(2012) P M Neilsen et al.   ONCOGENE

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

(2011) K. Vargova et al.   BLOOD

Role of microRNA-155 in autoimmunity

(2011) Rui-Xue Leng et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Unknown

(2011) Carlo Calissano et al.   MOLECULAR MEDICINE

Quantitative Proteomics Identify Novel miR-155 Target Proteins

(2011) Christopher Lößner et al.   PLoS One

The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia

(2010) Y. Herishanu et al.   BLOOD

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

(2010) S. Rossi et al.   BLOOD

MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application

(2010) S. Patrick Nana-Sinkam et al.   CANCER GENETICS AND CYTOGENETICS

Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

(2010) Torsten Haferlach et al.   JOURNAL OF CLINICAL ONCOLOGY

Karyotype-specific microRNA signature in chronic lymphocytic leukemia

(2009) R. Visone et al.   BLOOD

Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas

(2009) Irene M. Pedersen et al.   EMBO Molecular Medicine

MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes

(2009) Marek Mraz et al.   LEUKEMIA & LYMPHOMA

Inositol phosphatase SHIP1 is a primary target of miR-155

(2009) R. M. O'Connell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dicer Ablation Affects Antibody Diversity and Cell Survival in the B Lymphocyte Lineage

(2008) Sergei B. Koralov et al.   CELL

miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and highBIC/miR-155 expression

(2008) M Wang et al.   JOURNAL OF PATHOLOGY